GlucoTrack, Inc. GCTK
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.38M | 2.07M | 1.86M | 1.14M | 1.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.40M | 4.20M | 3.49M | 4.31M | 4.80M |
| Operating Income | -3.40M | -4.20M | -3.49M | -4.31M | -4.80M |
| Income Before Tax | -3.81M | -4.33M | -3.63M | -4.17M | -4.76M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.81M | -4.33M | -3.63M | -4.17M | -4.76M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.81M | -4.33M | -3.63M | -4.17M | -4.76M |
| EBIT | -3.40M | -4.20M | -3.49M | -4.31M | -4.80M |
| EBITDA | -3.38M | -4.18M | -3.47M | -4.30M | -4.79M |
| EPS Basic | -11.42 | -39.69 | -59.61 | -69.56 | -144.27 |
| Normalized Basic EPS | -6.64 | -24.80 | -37.26 | -43.48 | -90.17 |
| EPS Diluted | -11.42 | -39.69 | -59.61 | -69.56 | -144.27 |
| Normalized Diluted EPS | -6.64 | -24.80 | -37.26 | -43.48 | -90.17 |
| Average Basic Shares Outstanding | 333.90K | 109.20K | 60.90K | 60.00K | 33.00K |
| Average Diluted Shares Outstanding | 333.90K | 109.20K | 60.90K | 60.00K | 33.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |